Scleroderma

Common Name(s)

Scleroderma

Scleroderma is actually a group of rare conditions that harden and tighten the skin and connective tissue. Connective tissues provide support to many parts of the body including skin, bones, blood vessels, tendons, ligaments, and other organs. In some individuals scleroderma only affects the skin, but it can also harm blood vessels, lungs, kidneys, and the digestive tract. Symptoms associated with scleroderma vary but may include hardened thickened skin especially on hands or face that appears smooth and shiny, upset digestive system (acid reflux, difficulty swallowing, diarrhea, or constipation), shortness of breath, cold fingers and toes (Raynaud’s disease), ulcers on fingertips, dry eyes or mouth (Sjogren’s syndrome), swelling of hands, small red spots on face and chest (telangiectasia), painful swollen joints and muscle weakness.

Scleroderma is caused by an overproduction and accumulation of a protein that makes up the connective tissues called collagen. Doctors do not know what causes large amounts of collagen to be made and built up in body tissue. Scleroderma is more common in women than in men and typically onsets between the ages of 30 and 50. Scleroderma is not contagious, infectious, or cancerous.

Scleroderma takes many forms and affects many different areas of the body, making it difficult to diagnose. A doctor may perform a physical exam along with blood tests, breathing tests, a CT scan, and an echocardiogram of your heart to diagnose scleroderma. While there is no cure for scleroderma, treatments can lessen symptoms and help prevent further complication. Therapies can also be used to help lessen pain and improve mobility. If you or someone you know has been diagnosed with scleroderma, talk to your doctor about the most current treatment options. Support groups are also a good source of information and community support.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Scleroderma" for support, advocacy or research.

Association of Gastrointestinal Motility Disorders, Inc. (AGMD)

AGMD is a nonprofit international organization which serves as an integral educational resource concerning digestive motility diseases and disorders. It also functions as an important information base for members of the medical and scientific communities. In addition, it provides a forum for patients suffering from digestive motility diseases and disorders as well as their families and members of the medical community.

Last Updated: 28 Feb 2015

View Details
HealthyWomen

HealthyWomen (HW) is the nation's leading independent health information source for women. Our core mission is to educate, inform and empower women to make smart health choices for themselves and their families. For more than 20 years, millions of women have been coming to HW for answers to their most pressing and personal health care questions. Through our wide array of online and print publications, HW provides health information that is original, objective, reviewed by medical experts and reflective of the advances in evidence-based health research.

Last Updated: 9 Jul 2015

View Details
International Scleroderma Network

Our mission is to provide stellar worldwide research, support, education and awareness for scleroderma and related illnesses.

Last Updated: 18 Apr 2010

View Details
Logo
Raynaud's & Scleroderma Ireland

• To improve the lives of patients, their families and carers by providing support, advice and information. • To increase the awareness of Raynaud’s and Scleroderma amongst healthcare professionals, Government and Statutory agencies and the general public. • To work in partnership with appropriate healthcare professionals and agencies to promote and co-ordinate the attainment of the objectives of the strategy. • Maintain a working environment that fosters communication, teamwork and diversity among all members of staff- permanent, temporary and voluntary

Last Updated: 6 May 2014

View Details
Logo
Scleroderma Foundation

Our three-fold mission is to help patients and their families cope with scleroderma through mutual support programs, peer counseling, physician referrals, and educational information, to promote public awareness and education through patient and health professional seminars, literature, and publicity campaigns, and to stimulate and support research to improve treatment and ultimately find the cause of and cure for scleroderma and related diseases.

Last Updated: 19 Oct 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Scleroderma" for support, advocacy or research.

Association of Gastrointestinal Motility Disorders, Inc. (AGMD)

AGMD is a nonprofit international organization which serves as an integral educational resource concerning digestive motility diseases and disorders. It also functions as an important information base for members of the medical and scientific communities. In addition, it provides a forum for patients suffering from digestive motility diseases and disorders as well as their families and members of the medical community.

http://www.agmd-gimotility.org

Last Updated: 28 Feb 2015

View Details
HealthyWomen

HealthyWomen (HW) is the nation's leading independent health information source for women. Our core mission is to educate, inform and empower women to make smart health choices for themselves and their families. For more than 20 years, millions of women have been coming to HW for answers to their most pressing and personal health care questions. Through our wide array of online and print publications, HW provides health information that is original, objective, reviewed by medical experts and reflective of the advances in evidence-based health research.

http://www.healthywomen.org

Last Updated: 9 Jul 2015

View Details
International Scleroderma Network

Our mission is to provide stellar worldwide research, support, education and awareness for scleroderma and related illnesses.

http://www.sclero.org/

Last Updated: 18 Apr 2010

View Details
Logo
Raynaud's & Scleroderma Ireland

• To improve the lives of patients, their families and carers by providing support, advice and information. • To increase the awareness of Raynaud’s and Scleroderma amongst healthcare professionals, Government and Statutory agencies and the general public. • To work in partnership with appropriate healthcare professionals and agencies to promote and co-ordinate the attainment of the objectives of the strategy. • Maintain a working environment that fosters communication, teamwork and diversity among all members of staff- permanent, temporary and voluntary

http://www.irishraynauds.com

Last Updated: 6 May 2014

View Details
Logo
Scleroderma Foundation

Our three-fold mission is to help patients and their families cope with scleroderma through mutual support programs, peer counseling, physician referrals, and educational information, to promote public awareness and education through patient and health professional seminars, literature, and publicity campaigns, and to stimulate and support research to improve treatment and ultimately find the cause of and cure for scleroderma and related diseases.

http://www.scleroderma.org

Last Updated: 19 Oct 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Scleroderma" returned 952 free, full-text research articles on human participants. First 3 results:

[RACAND syndrome: distinct entity or initial presentation of systemic scleroderma].
 

Author(s): Monia Smiti Khanfir, Syrine Bellakhal, Fatma Said, Thouraya Ben Salem, Imed Ben Ghorbel, Mounir Lamloum, Amira Hamzaoui, Mohamed Habib Houman

Journal: Tunis Med. 2015 Jun;93(6):392.

 

Last Updated: 8 Dec 2015

Go To URL
Periodontal Conditions and Tumor Necrosis Factor-Alpha Level in Gingival Crevicular Fluid of Scleroderma Patients.
 

Author(s): Rina Elimelech, Yaniv Mayer, Yolanda Braun-Moscovici, Eli E Machtei, Alexandra Balbir-Gurman

Journal: Isr. Med. Assoc. J.. 2015 Sep;17(9):549-53.

 

Systemic sclerosis (SSc) is a chronic disease with prominent vasculopathy, inflammation, production of autoantibodies, and tissue fibrosis. Periodontitis is a chronic inflammatory oral condition manifesting as microbial infection, inflammation and destruction of the alveolar bone. ...

Last Updated: 2 Dec 2015

Go To URL
[Localized Scleroderma of Lower Extremities:Clinical and Magnetic Resonance Imaging Features].
 

Author(s): Feng-dan Wang, Hong-wei Wang, Zhi-hong Wu, Bo Hou, Bo Jiang, Yan Zhang, Feng Feng, Zheng-yu Jin, Xie Yuan

Journal: Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Aug;37(4):392-7.

 

To evaluate the clinical and musculoskeletal characteristics of localized scleroderma with lower extremities affected.

Last Updated: 13 Nov 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Scleroderma" returned 93 free, full-text review articles on human participants. First 3 results:

Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.
 

Author(s): Michael Hughes, Voon H Ong, Marina E Anderson, Frances Hall, Pia Moinzadeh, Bridget Griffiths, Eileen Baildam, Christopher P Denton, Ariane L Herrick

Journal: Rheumatology (Oxford). 2015 Nov;54(11):2015-24.

 

Digital vasculopathy (comprising RP, digital ulceration and critical digital ischaemia) is responsible for much of the pain and disability experienced by patients with SSc. However, there is a limited evidence base to guide clinicians in the management of SSc-related digital vasculopathy. ...

Last Updated: 14 Oct 2015

Go To URL
Interstitial lung disease in scleroderma.
 

Author(s): Sara R Schoenfeld, Flavia V Castelino

Journal: Rheum. Dis. Clin. North Am.. 2015 May;41(2):237-48.

 

Systemic sclerosis is a heterogeneous disease of unknown etiology with limited effective therapies. It is characterized by autoimmunity, vasculopathy, and fibrosis and is clinically manifested by multiorgan involvement. Interstitial lung disease is a common complication of systemic ...

Last Updated: 3 Apr 2015

Go To URL
Localized scleroderma: clinical spectrum and therapeutic update.
 

Author(s): Mariana Figueiroa Careta, Ricardo Romiti

Journal: An Bras Dermatol. ;90(1):62-73.

 

Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea ...

Last Updated: 12 Feb 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers and Patients With Cutaneous Scleroderma
 

Status: Recruiting

Condition Summary: Limited Scleroderma; Localized Scleroderma; Diffuse Scleroderma

 

Last Updated: 9 Nov 2015

Go to URL
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
 

Status: Not yet recruiting

Condition Summary: Scleroderma, Diffuse; Scleroderma, Systemic; Scleroderma, Limited; Sclerosis, Progressive Systemic; Skin Diseases; Connective Tissue Diseases; Pathologic Processes; Autoimmune Diseases

 

Last Updated: 10 Feb 2016

Go to URL
Gastroesophageal Reflux Treatment in Scleroderma
 

Status: Recruiting

Condition Summary: Gastroesophageal Reflux Disease; Systemic Sclerosis; Scleroderma

 

Last Updated: 17 Sep 2015

Go to URL